🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety, tolerability, single-a...
Status
Completed
Location
Parexel International
Start Date
2024-07-11
Trial ID
NCT06562114
Treatments Being Tested
This study involves 2 parts, Part A and Part B. The purpose of Part A is to...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2012-09
Trial ID
NCT01681186
Treatments Being Tested
The primary objective of this trial is to assess the effects of cytisinicli...
Status
Completed
Location
BlueClinical Phase I
Start Date
2022-10-17
Trial ID
NCT05566288
Treatments Being Tested
The primary objective of the Single Rising Dose (SRD) part (trial part 1) i...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2017-01-12
Trial ID
NCT03004404
Acute Myeloid Leukaemia (AML) is an aggressive and rare cancer of myeloid c...
Status
Active Not Recruiting
Location
City of Hope /ID# 154105
Start Date
2017-02-02
Trial ID
NCT02993523
Treatments Being Tested
This research study will evaluate inter-individual variability in the analg...
Status
Completed
Location
Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania School of Medicine
Start Date
2019-05-10
Trial ID
NCT03893175
Treatments Being Tested
The research aims of this proposal are: * Specific Aim 1: To test whether ...
Status
Terminated
Location
University of Mississippi Medical Center
Start Date
2021-05-27
Trial ID
NCT04770155
Treatments Being Tested
This is a randomized, placebo-controlled, 2-period crossover, escalating re...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-02-09
Trial ID
NCT02991859
This multicenter, international, Phase Ib/II trial consists of three stages...
Status
Completed
Location
HonorHealth Research Institute ? Bisgrove
Start Date
2012-01-11
Trial ID
NCT01485861
Treatments Being Tested
This study is a drug-drug interaction (DDI), pharmacokinetics (PK), safety ...
Status
Completed
Location
GSK Investigational Site
Start Date
2020-08-14
Trial ID
NCT04493931
Treatments Being Tested